These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9760480)

  • 1. Recent progress of the international harmonization of toxicological testing: toxicokinetics.
    Ohno Y
    J Toxicol Sci; 1998 Jul; 23 Suppl 2():265-7. PubMed ID: 9760480
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent progress of the international harmonization of toxicological testing: impact and implementation of ICH guidelines. International Conference Harmonization.
    Igarashi T
    J Toxicol Sci; 1998 Jul; 23 Suppl 2():255-7. PubMed ID: 9760477
    [No Abstract]   [Full Text] [Related]  

  • 3. Advantages of toxicokinetics in new drug development.
    Horii I
    Toxicol Lett; 1998 Dec; 102-103():657-64. PubMed ID: 10022331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the international harmonization of toxicological tests and subjects to be considered for its implementation. Proceedings of the 5th satellite symposium. Fukuoka, Japan, July 24, 1996.
    J Toxicol Sci; 1996 Dec; 21(5):409-547. PubMed ID: 9102474
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxicokinetics and physiologically based toxicokinetics in toxicology and risk assessment.
    Dixit R; Riviere J; Krishnan K; Andersen ME
    J Toxicol Environ Health B Crit Rev; 2003; 6(1):1-40. PubMed ID: 12587252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of ICH--toxicokinetics guidance and its practice--a useful approach for safety drug development].
    Tsuda M; Ohno Y
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1997; (115):1-14. PubMed ID: 9641814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifying toxicokinetics with antidotes.
    Baud FJ; Borron SW; Bismuth C
    Toxicol Lett; 1995 Dec; 82-83():785-93. PubMed ID: 8597143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development.
    Peck CC; Barr WH; Benet LZ; Collins J; Desjardins RE; Furst DE; Harter JG; Levy G; Ludden T; Rodman JH
    J Pharm Sci; 1992 Jun; 81(6):605-10. PubMed ID: 1355792
    [No Abstract]   [Full Text] [Related]  

  • 9. [Toxicology animal studies necessary for clinical research and registration of drugs for human use: conclusions of the International Harmonization Conference (I)].
    Rubio Terrés C; Duque I; Tristán C; Galende I
    Med Clin (Barc); 1993 Nov; 101(18):705-16. PubMed ID: 8114529
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxicodynetics: A new discipline in clinical toxicology.
    Baud FJ; Houzé P; Villa A; Borron SW; Carli P
    Ann Pharm Fr; 2016 May; 74(3):173-89. PubMed ID: 27107462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicokinetics: concepts and applications.
    Noda K
    J Toxicol Sci; 1998 Jul; 23 Suppl 2():214-7. PubMed ID: 9760468
    [No Abstract]   [Full Text] [Related]  

  • 12. Progress, innovation and regulatory science in drug development: the politics of international standard-setting.
    Abraham J; Reed T
    Soc Stud Sci; 2002 Jun; 32(3):337-69. PubMed ID: 12269340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodological approaches to the population analysis of toxicity data.
    Aarons L; Graham G
    Toxicol Lett; 2001 Mar; 120(1-3):405-10. PubMed ID: 11323200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Japanese view on a global toxicology testing program before ICH1 and after ICH4.
    Mitsumori K
    Toxicol Lett; 1998 Dec; 102-103():557-60. PubMed ID: 10022312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between pharmacokinetics and toxicokinetics.
    Welling PG
    Toxicol Pathol; 1995; 23(2):143-7. PubMed ID: 7569668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of modelling in toxicokinetics.
    Ings RM
    Arch Toxicol Suppl; 1994; 16():233-41. PubMed ID: 8192586
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of pharmacokinetics as an interpretive and predictive tool in chemical toxicology testing and risk assessment: a position paper on the appropriate use of pharmacokinetics in chemical toxicology.
    Frantz SW; Beatty PW; English JC; Hundley SG; Wilson AG
    Regul Toxicol Pharmacol; 1994 Jun; 19(3):317-37. PubMed ID: 8090955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sparse sampling for assessment of drug exposure in toxicological studies.
    Burtin P; Mentre F; van Bree J; Steimer JL
    Eur J Drug Metab Pharmacokinet; 1996; 21(2):105-11. PubMed ID: 8839683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of in vitro data in risk assessment.
    Bernauer U; Oberemm A; Madle S; Gundert-Remy U
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):176-81. PubMed ID: 15733212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant toxicokinetics: techniques for and interpretation of exposure data obtained during the conduct of toxicology studies.
    Dahlem AM; Allerheiligen SR; Vodicnik MJ
    Toxicol Pathol; 1995; 23(2):170-8. PubMed ID: 7569672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.